LB PHARMACEUTICALS INC - LBRX

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q1 2026 · Q4 2025
Value (USD)
Total reported value ($000)
$717.6M
QoQ value delta ($000)
+$165.8M (+30.05%)
Implied price effect (QoQ)
+9.87%
Shares
Total shares
29,342,882
QoQ shares delta
+4,553,307 (+18.37%)
Total shares held by funds (by quarter)

Market chart (LBRX)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q1 2026)

Top 25 only Full list
Partial Q1 2026 data: 77 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
Deep Track Capital, LP 82,680 3,352,804 1.35%
BlackRock, Inc. 60,931 2,470,845 0.0%
RA CAPITAL MANAGEMENT, L.P. 54,464 2,208,604 0.58%
TCG Crossover Management, LLC 45,279 1,839,489 1.3%
Commodore Capital LP 36,990 1,500,000 2.14%
Caligan Partners LP 34,628 1,438,070 2.3%
Spruce Street Capital LP 33,644 1,376,159 8.09%
JPMORGAN CHASE & CO 33,190 1,427,568 0.0%
Trails Edge Capital Partners, LP 32,535 1,319,362 7.45%
Nantahala Capital Management, LLC 25,964 1,052,894 0.96%
VANGUARD GROUP INC 24,774 1,112,978 0.0%
BALYASNY ASSET MANAGEMENT L.P. 22,778 923,694 0.03%
Logos Global Management LP 22,563 915,000 1.13%
VANGUARD CAPITAL MANAGEMENT LLC 22,062 894,653 0.0%
Alyeska Investment Group, L.P. 21,283 863,947 0.06%
Vivo Capital, LLC 19,728 800,000 1.64%
Nan Fung Group Holdings Ltd 15,552 630,657 12.82%
JENNISON ASSOCIATES LLC 13,272 538,216 0.01%
GEODE CAPITAL MANAGEMENT, LLC 12,783 518,228 0.0%
STATE STREET CORP 12,437 504,373 0.0%
CITADEL ADVISORS LLC 10,280 416,906 0.0%
GOLDMAN SACHS GROUP INC 8,971 363,799 0.0%
GREAT POINT PARTNERS LLC 7,398 300,000 1.7%
FMR LLC 5,487 222,508 0.0%
BAKER BROS. ADVISORS LP 4,932 200,000 0.03%